Show 10 5 10 15 20 50 100 250 Sort by year (new to old) Actions Download search results Subscribe to news feed Your filters: cql: author="Sandhu, Shahneen" or (type any "bookEditor issueEditor" and editor="Sandhu, Shahneen") Add to list Journal Article A1 open access Safety and efficacy of tarlatamab in patients with neuroendocrine prostate cancer : results from the Phase 1b DeLLpro-300 study Rahul Aggarwal, Sylvie Rottey (UGent) , Alice Bernard-Tessier, Begoña Mellado, Takeo Kosaka, Walter M Stadler, Lisa Horvath, Richard Greil, Bert O'Neil, Bilal A Siddiqui, et al. (2025) CLINICAL CANCER RESEARCH. 31(18). p.3854-3863 Add to list Conference Paper C3 Phase 1b study of tarlatamab in de novo or treatment-emergent neuroendocrine prostate cancer (NEPC) Rahul Raj Aggarwal, Sylvie Rottey (UGent) , Alice Bernard-Tessier, Begona Mellado-Gonzalez, Takeo Kosaka, Walter Michael Stadler, Shahneen Sandhu, Brian Yu, Crystal Shaw, Chia-Hsin Ju, et al. (2024) JOURNAL OF CLINICAL ONCOLOGY. In Journal of Clinical Oncology 42(16, Supplement S). Add to list Journal Article A1 Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD) : a multicentre, open-label, phase 2 trial Matthew R Smith, Howard I Scher, Shahneen Sandhu, Eleni Efstathiou, Primo N Lara, Evan Y Yu, Daniel J George, Kim N Chi, Fred Saad, Olof Ståhl, et al. (2022) LANCET ONCOLOGY. 23(3). p.362-373